Vijaya Diagnostic Centre Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
May 08, 2024 at 06:47 am
Share
Vijaya Diagnostic Centre Limited reported earnings results for the fourth quarter and full year ended March 31, 2024. For the fourth quarter, the company reported sales was INR 1,552.05 million compared to INR 1,209.93 million a year ago. Revenue was INR 1,584.56 million compared to INR 1,255.12 million a year ago. Net income was INR 334.51 million compared to INR 274.93 million a year ago. Basic earnings per share from continuing operations was INR 3.27 compared to INR 2.69 a year ago. Diluted earnings per share from continuing operations was INR 3.26 compared to INR 2.68 a year ago.
For the full year, sales was INR 5,478.05 million compared to INR 4,592.23 million a year ago. Revenue was INR 5,686.23 million compared to INR 4,733.73 million a year ago. Net income was INR 1,188.25 million compared to INR 846.32 million a year ago. Basic earnings per share from continuing operations was INR 11.62 compared to INR 8.29 a year ago. Diluted earnings per share from continuing operations was INR 11.59 compared to INR 8.26 a year ago.
Vijaya Diagnostic Centre Limited is an India-based company. The Company is engaged in the business of providing comprehensive range of diagnostic services, spanning pathological investigations, basic and high-end radiology, nuclear medicine, and related healthcare services. The Company operates through the Diagnostic Services segment. Its services include clinical pathology, microbiology, hematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, computerized tomography (CT) scan, magnetic resonance imaging (MRI) scan, ultrasound, x-ray, cardiology, gastroenterology, nuclear medicine, pet CT, and MRI -3t. It operates approximately 121 diagnostic centers in 20 cities spread across India.